# Lisata Therapeutics, Inc.: Form 8-K, filed Apr 17, 2024

- Company: [Lisata Therapeutics, Inc.](/companies/lsta.md) (CIK 320017)
- Form: 8-K
- Filed: 2024-04-17
- Accepted by EDGAR: Apr 17, 2024, 16:04 ET
- Period: 2024-04-15
- Accession: 0000320017-24-000013
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/320017/000032001724000013/clbs-20240415.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/320017/000032001724000013/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/320017/000032001724000013/clbs-20240415.htm

Filed Apr 17, 2024.
Source: SEC EDGAR, the filing index for accession 0000320017-24-000013. Last ingested by Listed: Nov 14, 2026, 19:21 ET. No prices; not investment advice.
